VCIT vs XLV
Vanguard Intermediate-Term Corporate Bond ETF vs Health Care Select Sector SPDR Fund
VCIT$79.32
Vanguard Intermediate-Term Corporate Bond ETF
Intermediate-term investment-grade corporate bonds.
Expense: 0.03%Yield: 5.01%
XLV$187.94
Health Care Select Sector SPDR Fund
S&P 500 health care sector.
Expense: 0.08%Yield: 1.38%
Quick take
- • VCIT has the lower expense ratio at 0.03% vs 0.08% for XLV.
- • VCIT pays a higher dividend yield (5.01%).
Side-by-side metrics
| Metric | VCIT | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.08% |
Dividend yield Trailing 12-month yield. | 5.01% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $70.82B | $49.10B |
YTD return | -0.71% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.06 | 0.41 |
P/E ratio | — | 30.63 |
Last price | $79.32 | $187.94 |
Inception | — | — |
Issuer | Vanguard | State Street |
VCIT top holdings
Holdings data unavailable for VCIT.
XLV top holdings
Top holdings · XLV
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
Sector breakdown · XLV
Healthcare100.0%
About VCIT
VCIT (Vanguard Intermediate-Term Corporate Bond ETF) is Intermediate-term investment-grade corporate bonds. Managed by Vanguard, the fund carries $70.8B in assets under management, an expense ratio of 0.03%, a dividend yield of 5.01%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.